Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

Dmitriy Zamarin, MD, PhD

Medical Oncologist


Dmitry Zamarin is a medical oncologist specializing in the care of women with gynecologic cancers, including cervical, ovarian, and endometrial cancers. Zamarin’s clinical and laboratory research is focused on the development of new ways to use the immune system to treat cancer, and he is involved in clinical trials evaluating novel immunotherapy drugs in patients with cancer. He is particularly interested in genetically engineered oncolytic viruses, an emerging class of immune therapeutic drugs that have shown significant clinical promise in the recent years. By manipulating the oncolytic viruses and the immune system, Zamarin is exploring different ways to enhance the immune recognition of tumors and to develop novel treatment strategies that would be applicable to different cancer types.

Education & Training

  • Mount Sinai School of Medicine, New York, NY, MD, PhD
  • Mount Sinai Medical Center, New York, NY, Residency
  • Memorial Sloan Kettering Cancer Center, New York, NY, Fellowship

Awards & Honors

  • 2014: Bladder Cancer Awareness Network Young Investigator Award
  • 2013: Conquer Cancer Foundation ASCO Young Investigator Award, Damon Runyon Foundation Fellowship Award
  • 2012: Celgene Future Leaders in Hematology Award
  • 2011: American Society of Hematology Abstract Achievement Award
  • 2010: Mount Sinai School of Medicine Department of Medicine Award for excellence in research
  • 2008: Mount Sinai School of Medicine Department of Medicine Research Fellowship Grant, Barry Coller Award for Excellence in Clinical Medicine, Mount Sinai School of Medicine
  • 2006: Mount Sinai School of Medicine Doctoral Dissertation Award
  • 2005: American Society for Virology Travel Award
  • 2004: NYU/Mount Sinai School of Medicine Graduate Student Grant in Virology